Table 2.
Received Treatments in the ICU (n = 75)
| Therapy | n (%) |
|---|---|
| Anti-infective agents | |
| Oseltamivir | 3 (4) |
| Antibacterial | 71 (95) |
| Antimalarial | 4 (5) |
| Antifungal | 12 (16) |
| Antithrombotic agents | |
| Initial dosing | |
| Thromboprophylaxis | 52 (69) |
| Intermediate | 3 (4) |
| Therapeutic anticoagulation | 20 (27) |
| Maximal dosing | |
| Thromboprophylaxis | 31 (41) |
| Intermediate | 1 (1) |
| Therapeutic anticoagulation | 43 (57) |
| Reason for anticoagulation | |
| Empirical | 5 (12) |
| Cardiac indication | 16 (37) |
| VTE | 14 (33) |
| CRRT / ECMO | 4 (9) |
| Antiplatelet therapy use | 20 (27) |
| Immunomodulating agents | |
| Corticosteroids | 35 (47) |
| Other | 0 (0) |
| Non-pharmacological | |
| Invasive mechanical ventilation | 42 (56) |
| Non-invasive positive-pressure ventilation | 16 (21) |
| High-flow nasal cannula | 2 (3) |
| Extracorporeal membrane oxygenation | 1 (1) |
| Continuous renal replacement therapy | 7 (9) |
| IMV-specific support | |
| NMB: bolus only | 6/43 (14) |
| NMB: continuous infusion | 16/43 (37) |
| Nitric oxide | 15/43 (35) |
| Prone position | 11/43 (26) |
| Percutaneous tracheostomy | 10/43 (23) |
CRRT = continuous renal replacement therapy; ECMO = extracorporeal membrane oxygenation; NMB = neuromuscular blockers; VTE = venous thromboembolism, IMV = invasive mechanical ventilation